REVALESKIN - 0145-2810-03 - (octinoxate and oxybenzone)

Alphabetical Index


Drug Information of REVALESKIN

Product NDC: 0145-2810
Proprietary Name: REVALESKIN
Non Proprietary Name: octinoxate and oxybenzone
Active Ingredient(s): 75; 40    mg/mL; mg/mL & nbsp;   octinoxate and oxybenzone
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of REVALESKIN

Product NDC: 0145-2810
Labeler Name: Stiefel Laboratories Inc
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20110429

Package Information of REVALESKIN

Package NDC: 0145-2810-03
Package Description: 1 BOTTLE in 1 CARTON (0145-2810-03) > 50 mL in 1 BOTTLE

NDC Information of REVALESKIN

NDC Code 0145-2810-03
Proprietary Name REVALESKIN
Package Description 1 BOTTLE in 1 CARTON (0145-2810-03) > 50 mL in 1 BOTTLE
Product NDC 0145-2810
Product Type Name HUMAN OTC DRUG
Non Proprietary Name octinoxate and oxybenzone
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20110429
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Stiefel Laboratories Inc
Substance Name OCTINOXATE; OXYBENZONE
Strength Number 75; 40
Strength Unit mg/mL; mg/mL
Pharmaceutical Classes

Complete Information of REVALESKIN


General Information